Inhibition of ASS1 can reduce proliferation of breast or colorectal cancer (45, 46) and moderately affected BAP1-altered MPM cells expressing ASS1, consistent with the idea that ASS1 can support MPM cell survival (54). Here, ASS1 is linked to colorectal cancer.